Carnegie Investment Bank Equity Analyst Jesper Ilsøe notes that the US Food and Drug Administration approval of Stallergenes Greer's tablet for dust mite allergies may lead to a further expansion of the market for treating allergies with tablets, which is currently relatively small.
He expects that in the long term, Stallergenes will take over around 30 percent of the market for treating dust mite allergies with tablets. He further estimates that other vaccine companies like ALK can lean back and enjoy the increased competition.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Fruergaard leveraging experience from Danish partnerships in key roles in Brussels
Experiences from Danish climate partnerships are among the tools that can be leveraged when Novo Nordisk CEO Lars Fruergaard begins stepping up efforts in the life science sector’s central organs in Brussels. ”I’ve been fired up by the intimacy and shared vision we could see in Denmark,” he tells MedWatch.
Stallergenes slapped with injunction
There are still issues with Stallergenes Greer’s factory in Antony, the Agence Nationale de Sécurité du Médicament has concluded.
Overview: Pharma giants and Bavarian Nordic fight over billion-dollar vaccine market
There is currently no approved vaccine for RSV, which causes serious illness and can be deadly for newborns and the elderly. The race to come first to the vaccine market is heating up, while more companies are close to completing phase III studies. Get an overview of their progress here.
Eargo raises USD 100m from investment firm
US-based Eargo, which is run by a Dane, has entered an agreement with an investment firm which is injecting USD 100m into the company.
US authorities expand monkeypox vaccine plan
More Americans will be offered a monkeypox vaccine.
Device Associate Director/Senior Project Leader 
Senior Project Manager (GMP - Life Science) 
Specialist within Project Management and Launch, Regulatory Affairs Life Cycle Management 
Senior Electronics Engineer 
Regulatory Affairs Manager - Maternity Cover 
Senior Manager/Associate Director, Global Regulatory Affairs, CMC 
KLIFO is looking for a Project Director for our office in Denmark or Germany or Sweden 
Nordic Medical Advisor 
Quality Management System Compliance Department Manager 
Senior Scientist for Analytical Development 
Training Supporter with high drive 
Global Product Manager - Pulmonology 
Chair of the Board